ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1132

Prevalence of Knee Pain in Ultramarathon Runners

Victoria M. Kelly1, Martin Hoffman2, Bharathi Lingala3, Mihoko Bennett4 and Eswar Krishnan5, 1Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, 2Physical Medicine and Rehabilitation, Department of Veteran's Affairs, Northern California Health Care System and University of California Davis Medical Center, Sacramento, CA, 3Stanford University, Palo Alto, CA, 4Pediatrics, Stanford University, Palo Alto, CA, 5Division of Rheumatology, Stanford University, Palo Alto, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, Osteoarthritis, Pain and physical activity

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Prevalence of Knee Pain in Ultramarathon Runners

Background/Purpose: Approximately one in four Americans suffer from frequent knee pain. While some studies have linked long-distance running with the risk for knee pain, others have not observed such associations. Since the proposed mechanism of such a link involves mechanical stress to the joints, greater lifetime running miles should be associated with a greater risk for knee pain and an earlier age of onset. We tested these expectations by cross sectional analysis of data from the baseline questionnaire of a new cohort of ultramarathon runners.

Methods: The ULTRA study is a cohort of runners who have participated in at least one ultramarathon race (≥50 kilometers) in their lifetime. This study has been enrolling participants since November 2011. For the purposes of this analysis, “knee pain” was defined as “any knee pain in the past 6 months”, as there were almost no individuals with chronic-frequent knee pain in this cohort of high functioning individuals.  To assess the impact of mileage on knee pain, we performed a logistic regression model, where the dependent variable was knee pain and independent variables were quartiles of lifetime running distance, age, body mass index (BMI) and current running status.  Ex-runners were defined as those who have not run regularly in the preceding 12 months.

Results: Of the 1,083 runners included in the present analysis, 68% were men and 6% were classified as ex-runners. The mean age, and BMI were 44 years and 27 kg/square meters respectively. After adjusting for age, gender and BMI, the prevalence of knee pain was higher in those with lower lifetime mileage, both in runners and ex-runners. Overall rates of knee pain did not differ between runners and ex-runners (47% vs. 48%), and confidence intervals overlapped significantly for knee pain within each mileage group (see Figure).  In the logistic regression model, runners in the highest distance quartile (>25,000 miles) were the least likely to report knee pain, OR 0.5 (CI 0.4-0.8), suggesting that lifetime running distance is inversely correlated with knee pain.

Conclusion: Knee pain was more common among low mileage runners; the causal direction of this association can be ascertained in prospective studies. There was no difference in overall knee pain between current and ex-runners.


Disclosure:

V. M. Kelly,
None;

M. Hoffman,
None;

B. Lingala,
None;

M. Bennett,
None;

E. Krishnan,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-knee-pain-in-ultramarathon-runners/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology